Sodium intake increases cardiovascular disease risk in CKD patients
While high sodium intake can increase the chance of cardiovascular disease in anyone, patients already dealing with chronic kidney disease could be dealing with even more risk. A new study, published in the Journal of the American Medical Association, found a link between high sodium intake and a higher chance of developing CVD.
The study included over 3,000 participants with CKD with an average age of 58, looking specifically at their frequency of cardiovascular disease. By analyzing urinary samples, the researchers from Tulane University School of Public Health and Tropical Medicine in New Orleans found the link, though they say further investigation is needed.
"These findings, if confirmed by clinical trials, suggest that moderate sodium reduction among patients with CKD and high sodium intake may lower CVD risk," the authors of the study explained.
There are plenty of ways for sufferers for CKD to reduce their sodium consumption, especially by looking for salt alternatives, like seaweed. Award-winning research from the UK's Centre for Food Innovation at Sheffield Hallam University found that Seagreens® seaweed contains only 3 percent sodium compared to the 40 percent in normal salts. Food manufacturers in Europe have been using seaweed for several years, confirming it a successful and healthy salt replacement in food. Plus, it also contains a range of nutrients, benefiting other health efforts, such as digestion and weight regulation.
To reduce the sodium in your diet, try Seagreens Mineral Salt. Every Seagreens product contains all the minerals, micronutrients, trace elements and vitamins that can be found in all-natural, organic seaweed. Seagreens organic wild wrack seaweeds are produced to the company's award-winning proprietary standard (patents pending) among Scotland's remote Western Islands in pristine Grade A waters. All Seagreens products are organic, kosher and certified free from allergens and contaminants.